Literature DB >> 1279326

Treatment of minimal residual disease in acute leukemia--focus on immunotherapeutic options.

B Simonsson1, B I Nilsson, J M Rowe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279326

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  1 in total

1.  Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.

Authors:  F Vaz; M R Silva; J L Ascensao
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.